S. 660 · 116th Congress
Efficiency and Transparency in Petitions Act
- Stage
- In committee
- Sponsor
- Mike Braun
- Introduced
- 2019-03-05
- Latest action
- 2019-03-05 · Introduced in Senate
Summary
Efficiency and Transparency in Petitions Act
This bill requires a petition regarding a pending generic drug or biological product application to be submitted to the Food and Drug Administration (FDA)within one year of when the petitioner discovers the issue that is the basis for the petition.
The FDA may grant a waiver of the one-year deadline.